• -
54 Results
Blue stem cell under microscope
Unproven Stem Cell Interventions: A Global Public Health Problem Requiring Global Deliberation
The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004
Kirstin R.W. Matthews, Zubin Master, Mohamed Abou-el-Enein June 9, 2021
Stethoscope on top of chart
Private Equity Investments In Health Care: An Overview Of Hospital And Health System Leveraged Buyouts, 2003–17
Private equity investment in hospitals has grown substantially in the 21st century, and it accelerated in the years leading up the COVID-19 pandemic. In this study of short-term acute care hospitals acquired by private equity firms, the authors find they not only have higher markups and profit margins, they’re also slower to expand their staffs.
Anaeze C. Offodile II, Vivian Ho May 4, 2021
Dialysis machine
Pre-ESKD Nephrology Care and Employment at the Start of Dialysis
The authors found that six months of pre–end-stage kidney disease nephrology care did not significantly improve the likelihood that patients would remain employed when they started dialysis. This finding underscores the need to identify effective methods to help patients stay employed when they transition to dialysis.
Vivian Ho, Kevin Erickson May 18, 2020